Certainly quality and measured progress.
Massive run way to becoming a, if not THE, dominant MC player in Oz in non-opiate pain management.
That being said, it's time for the long awaited sell down back to the 40c range as I imagine has been in the works for weeks now.
Ann: June 2019 Quarterly Activities and Cashflow Reports, page-4
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)